IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Dafna Capital Management LLC

Portfolio Profile

CIK: 0001389933 | LOS ANGELES, CA

Investment Profile

Style

Value

Turnover

Medium

Orientation

Concentrated trader
$524.4M
AUM
88
Positions
56.21%
Top 10 Conc.
79.78%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Revolution Medicines Inc(RVMD)562,630$105.4M20.09%
2Spdr S&P Biotech ETF(XBI)196,505$31.1M5.93%
3Compass Pathways PLC(CMPS)2,011,952$28.5M5.43%
4Stereotaxis Inc(STXS)13,680,554$23.5M4.49%
5Nektar Therapeutics(NKTR)318,380$22.2M4.24%
6

Sector Allocation

Latest filing, equity positions only

Healthcare89.45% · $469.0M
Unclassified10.55% · $55.3M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare84.44%89.45%+5.01%
Unclassified15.56%10.55%-5.01%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$321.5M | 75 pos.
$417.3M | 76 pos.
$439.3M | 72 pos.
$418.6M | 83 pos.
$423.3M | 84 pos.
$393.4M | 82 pos.
Denali Therapeutics Inc(DNLI)
739,014
$19.0M
3.62%
7Ideaya Biosciences Inc(IDYA)497,240$18.5M3.53%
8Atricure Inc(ATRC)597,431$16.7M3.19%
9Xenon Pharmaceuticals Inc(XENE)250,772$15.1M2.89%
10Cytokinetics Inc(CYTK)171,998$14.7M2.79%
Cap SizePrev %Curr %Change
Mid Cap29.81%28.72%-1.09%
Large Cap18.65%27.9%+9.25%
Small Cap25.67%23.28%-2.39%
Unclassified15.56%10.55%-5.01%
Micro Cap10.32%9.55%-0.77%
$352.7M | 83 pos.
$362.3M | 76 pos.
$404.8M | 75 pos.
$430.5M | 77 pos.
$439.6M | 83 pos.
$524.4M | 88 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

16
New
11
Closed
17
Increased
27
Decreased
28
Unchanged